ASCO® 2023 Insights: "Determinants of Resistance to Nivo Monotherapy Investigated Through Genomic and Transcriptomic Analysis of RCC Tumors From the HCRN GU16-260 Study"

61 views
July 12, 2023
0 Comments
Login to view comments. Click here to Login
GU